You are here

Clinical Trials: Cord Blood

Conditions:   High Risk Myeloid Malignancies;   Cord Blood Transplant
Intervention:   Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors:   ExCellThera inc.;   Memorial Sloan Kettering Cancer Center
Not yet recruiting
Condition:   Alzheimer's Disease
Intervention:   Biological: human umbilical cord blood derived mesenchymal stem cells
Sponsors:   Samsung Medical Center;   Medipost Co Ltd.
Not yet recruiting
Condition:   Congenital Heart Disease, SRV Dependent
Intervention:   Biological: Autologous mononuclear cells
Sponsors:   Timothy J Nelson, MD, PhD;   Mayo Clinic;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospitals and Clinics of Minnesota;   Children's Hospital Colorado;   Ochsner Health System;   Children's of Alabama;   Children's Hospital Medical Center, Cincinnati;   The Hospital for Sick Children
Not yet recruiting
Condition:   Alveolar Cleft
Intervention:   Procedure: stem cell transplantation
Sponsor:   Makerere University
Not yet recruiting
Condition:   Ulcerative Colitis
Interventions:   Drug: Prednisone;   Drug: Azathioprine;   Drug: Adalimumab;   Biological: umbilical cord blood mononuclear cells
Sponsor:   Shandong Qilu Stem Cells Engineering Co., Ltd.
Condition:   Autism Spectrum Disorder
Intervention:   Other: umbilical cord blood mononuclear stem cells
Sponsor:   St. Petersburg Bekhterev Research Psychoneurological Institute
Active, not recruiting
Condition:   Leukemia, Myelomonocytic, Acute
Intervention:   Drug: umbilical cord blood
Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
Not yet recruiting
Condition:   Acute Myeloid Leukemia
Interventions:   Drug: Cyclophosphamide-Fludarabine (Cy/Flu);   Drug: oNKord®
Sponsor:   Glycostem Therapeutics BV
Not yet recruiting
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes
Interventions: Drug: Venetoclax; Drug: Placebo; Combination Product: Standard chemotherapy; Other: Autologous stem cell transplantation; Other: Allogeneic stem cell transplantation
Sponsors: University of Ulm; Stichting Hemato-Oncologie voor Volwassenen Nederland
Conditions:   Sickle Cell Disease;   Umbilical Cord Blood;   Hematopoietic Cell Proliferation
Intervention:   Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors:   ExCellThera inc.;   California Institute for Regenerative Medicine (CIRM)
Not yet recruiting